Eight commonly prescribed anti-cancer drugs will soon enter India's National List of Essential Medicines (NLEM).
Dabur Pharma, a leading player in the domestic oncology segment, is busy finalising its marketing strategies for EU, the US and Australia.
The government regulates prices of all other medicines.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances